Deutsche Bank AG has disclosed terms for a new issuance of 6.00% Fixed Rate Callable Senior Debt Funding Notes due July 31, 2051, in a pricing supplement filed with U.S. regulators. The notes, designated Pricing Supplement No. E487, are expected to price on or about July 29, 2026, and settle on or about July 31, 2026, with Deutsche Bank Securities Inc. acting as the sole agent. The offering carries a 25-year maturity and includes an optional redemption feature exercisable by the issuer, making the structure a notable long-dated callable instrument for investors monitoring Deutsche Bank's funding activity. Investors should be aware that the notes are subject to European resolution authority powers, including the potential write-down or conversion of principal and interest under applicable bail-in rules.

Key Points

  • NASDAQ: DZZ — Deutsche Bank AG structured notes vehicle
  • Deutsche Bank AG has disclosed a new issuance of 6.00% Fixed Rate Callable Senior Debt Funding Notes due July 31, 2051, designated Pricing Supplement No. E487
  • Notes priced at 100.00% of par ($1,000 minimum denomination); expected trade date on or about July 29, 2026, and settlement on or about July 31, 2026; CUSIP 25160YFU7 / ISIN US25160YFU73
  • Investors should watch the optional redemption schedule commencing July 31, 2028, and monitor European resolution authority developments that could affect payment obligations

Deutsche Bank's 6.00% Senior Debt Notes: Structure and Principal Terms

The pricing supplement discloses that Deutsche Bank AG is the issuer of unsecured, unsubordinated senior preferred obligations carrying a fixed annual interest rate of 6.00%. The notes have a stated maturity date of July 31, 2051, making them a 25-year instrument from the expected settlement date. Interest is payable annually in arrears on the 31st calendar day of each July, commencing July 31, 2027, and continuing through the maturity date or any applicable optional redemption date. The day count convention applied is an unadjusted 30/360 basis, as stated in the disclosure.

The notes are offered in minimum denominations of $1,000, described in the filing as the "Principal Amount," with purchases permitted in integral multiples above that threshold. The issue price is set at 100.00% of the principal amount per note. The total aggregate principal amount of the offering was not disclosed as a finalized figure in this preliminary pricing supplement, as certain fields remained subject to completion at the time of filing. The company did not disclose this figure in the filing.

Optional Redemption Dates and Callable Feature Explained

One of the defining structural features of this offering is Deutsche Bank's retained right to redeem the notes in its sole discretion, though only in whole and not in part. According to the disclosure, optional redemption dates fall semi-annually on the 31st calendar day of each January and July, commencing July 31, 2028, and ending on January 31, 2051. The issuer is required to give not less than five business days' prior notice before exercising this redemption option, and any redemption remains subject to regulatory approval.

Upon redemption, noteholders would receive 100% of the principal amount together with any accrued but unpaid interest as of the redemption date. The callable structure introduces reinvestment risk for investors, as Deutsche Bank retains the unilateral right to retire the notes at par during periods that may coincide with lower market interest rates. The filing makes clear that this redemption right rests entirely with the issuer, with no corresponding put right granted to noteholders.

Eligible Liabilities Qualification and Regulatory Capital Context

The pricing supplement states that the notes are intended to qualify as eligible liabilities for the minimum requirement for own funds and eligible liabilities, commonly referred to as MREL, of Deutsche Bank AG. MREL is a regulatory requirement under European Union banking rules designed to ensure that institutions maintain a sufficient buffer of loss-absorbing instruments that can be written down or converted in a resolution scenario. The notes' intended MREL eligibility places them within a broader European bank regulatory framework and signals their function beyond conventional deposit-taking or standard bond issuance.

This regulatory context is directly relevant to investors because the MREL-eligible classification means the notes are explicitly designed to absorb losses in a resolution event. The filing is unambiguous that all payments on the notes, including both interest payments and repayment of principal at maturity, are subject to the credit of the issuer and to the potential application of resolution measures. Investors should treat this not as a theoretical risk disclosure but as a core structural characteristic of the instrument as designed under EU law.

Resolution Measures, Bail-In Risk, and Investor Consent

The pricing supplement devotes significant disclosure to what it terms "Resolution Measures," rooted in the European Bank Recovery and Resolution Directive (Directive 2014/59/EU, as amended, referred to in the filing as the BRRD) and the German Recovery and Resolution Act (Sanierungs- und Abwicklungsgesetz). The filing states that from January 1, 2016, the power to initiate resolution measures applicable to significant banking groups such as Deutsche Bank Group within the European Banking Union was transferred to the European Single Resolution Board, which cooperates with the European Central Bank, the European Commission, and national resolution authorities.

Under the terms disclosed, by acquiring the notes, investors are deemed to have irrevocably consented to any resolution measure that the competent resolution authority may impose. These measures can include writing down payments on the notes, potentially to zero; converting the notes into ordinary shares of the issuer, a group entity, or a bridge bank; transferring the notes to another entity; amending or varying the terms and conditions of the notes; or outright cancellation of the notes. The filing explicitly states that the imposition of any such resolution measure will not constitute a default or an event of default under the notes. Investors who acquire these instruments are therefore waiving the right to assert a default claim in such a scenario.

Irrevocable Investor Consent and Waiver of Claims

The disclosure goes further in describing the scope of investor consent embedded in the purchase of these notes. According to the pricing supplement, investors are deemed irrevocably to have agreed to be bound by, to acknowledge, and to accept any resolution measure and any amendment, modification, or variation of the terms and conditions of the notes made to give effect to a resolution measure. Additionally, the filing states that investors will have no claim or other right against Deutsche Bank AG arising out of any resolution measure that becomes applicable.

This is a meaningful legal provision that sets these notes apart from conventional unsecured corporate bonds. Investors who purchase these notes are explicitly forgoing certain legal remedies that would typically be available in a default scenario. The pricing supplement directs prospective investors to the sections titled "Resolution Measures" beginning on page 75 of the accompanying prospectus and "Resolution Measures and Deemed Agreement" beginning on page PS-2 of the pricing supplement itself for fuller detail on these consent provisions.

Offering Economics: Price to Public, Discounts, and Agent Commissions

The pricing supplement sets out the economic terms of the distribution in a clear table format. The price to the public per note is $1,000.00. Deutsche Bank Securities Inc., referred to in the filing as DBSI, will receive discounts and commissions of up to $50.00 per note, resulting in proceeds to Deutsche Bank AG of $950.00 per note. DBSI may allow selected dealers a selling concession of up to $50.00 per note, depending on market conditions relevant to the value of the notes at the time an order is submitted.

The filing further notes that for eligible institutional investors and investors purchasing through fee-based advisory accounts, the price to the public will vary based on then-current market conditions and negotiated pricing. However, the disclosure specifies that the price for such investors will not be less than $950.10 per note and will not be more than $1,000 per note. Dealers selling to these categories of investors may forgo some or all of their selling concessions. The total proceeds figures for the overall offering were not finalized in this preliminary supplement, as the total offering size remained subject to completion.

DBSI's Role as Affiliated Agent and Conflict of Interest Disclosure

The pricing supplement explicitly identifies Deutsche Bank Securities Inc. as both the agent for this offering and an affiliate of Deutsche Bank AG, the issuer. This dual role constitutes a conflict of interest, which the filing acknowledges and directs investors toward the section titled "Supplemental Plan of Distribution (Conflicts of Interest)" within the pricing supplement for further information. The affiliated agent structure is a common feature in bank-issued structured note offerings but warrants investor attention when assessing distribution independence and pricing fairness.

The disclosure does not provide further quantitative breakdown of how the conflict of interest is managed or mitigated beyond the directional reference to the relevant supplemental section. The filing makes clear that DBSI's receipt of commissions of up to $50.00 per note creates a financial incentive for the affiliate to promote the notes, a dynamic that investors evaluating the offering's pricing should factor into their analysis. The immediate share price impact was not clear from available public information.

Settlement Mechanics, Book-Entry Delivery, and Listing Status

The notes are expected to price on or about July 29, 2026, as the trade date, with settlement expected on or about July 31, 2026, the settlement date. Delivery of the notes will be made exclusively in book-entry form through The Depository Trust Company, commonly referred to as DTC. This means individual investors will not receive physical certificates and will hold their interest through the standard DTC custodial chain via their brokerage or financial institution.

The filing confirms that the notes will carry the CUSIP number 25160YFU7 and the ISIN US25160YFU73, which are the identifiers by which the notes will be tracked across financial systems. Notably, the pricing supplement states that the notes will have no listing on any securities exchange. The absence of an exchange listing means there will be no organized secondary market for the notes, and investors who wish to sell prior to maturity or prior to an optional redemption may face limited liquidity and potentially significant market impact costs when seeking a buyer.

Key Risk Factors Highlighted in the Disclosure

The pricing supplement directs investors to multiple risk factor sections across the offering documents. Specifically, the filing references "Risk Factors" beginning on page PS-6 of the accompanying prospectus supplement, page 20 of the accompanying prospectus, and "Selected Risk Considerations" beginning on page PS-5 of the pricing supplement itself. Among the risks most prominently flagged in the body of the pricing supplement is the resolution and bail-in risk discussed at length in the "Resolution Measures and Deemed Agreement" section.

The filing includes an explicit warning that if any resolution measure becomes applicable to Deutsche Bank AG, investors may lose some or all of their investment in the notes. Additionally, the disclosure emphasizes that the notes are not deposits or savings accounts and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other U.S. or foreign governmental agency or instrumentality. This FDIC non-coverage disclosure is particularly important for retail investors who might otherwise conflate these instruments with bank deposit products in terms of safety of principal.

Registration and Regulatory Status of the Notes

The notes are issued pursuant to Registration Statement No. 333-278331, filed by Deutsche Bank AG. The pricing supplement accompanies a prospectus supplement dated April 26, 2024, and a prospectus also dated April 26, 2024, which together form the broader shelf registration framework under which this and other Deutsche Bank note issuances are made. The preliminary pricing supplement was dated July 14, 2026, indicating that certain terms remained subject to finalization before pricing on or about July 29, 2026.

As is standard for registered offerings of this nature, the filing carries the customary regulatory disclaimer that neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or adequacy of the pricing supplement or the accompanying prospectus supplement or prospectus. The filing further states that any representation to the contrary is a criminal offense, reaffirming the standard legal perimeter around the offering's promotional and distribution activities.